172 related articles for article (PubMed ID: 34073974)
41. Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine.
Bannister A; Dissanayake D; Kowalewski A; Cicon L; Bromma K; Chithrani DB
Bioengineering (Basel); 2020 Jun; 7(2):. PubMed ID: 32545909
[TBL] [Abstract][Full Text] [Related]
42. Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC-1).
Wang L; Xu J; Yan Y; Liu H; Karunakaran T; Li F
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1617-1627. PubMed ID: 31014134
[TBL] [Abstract][Full Text] [Related]
43. Biologic effect of neurogenesis in pancreatic cancer.
He D; Manzoni A; Florentin D; Fisher W; Ding Y; Lee M; Ayala G
Hum Pathol; 2016 Jun; 52():182-9. PubMed ID: 26980040
[TBL] [Abstract][Full Text] [Related]
44. An oxidation responsive nano-radiosensitizer increases radiotherapy efficacy by remolding tumor vasculature.
Wang X; Niu X; Sha W; Feng X; Yu L; Zhang Z; Wang W; Yuan Z
Biomater Sci; 2021 Sep; 9(18):6308-6324. PubMed ID: 34519724
[TBL] [Abstract][Full Text] [Related]
45. Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Silveira MJ; Castro F; Oliveira MJ; Sarmento B
Biomater Sci; 2021 May; 9(9):3228-3243. PubMed ID: 33949441
[TBL] [Abstract][Full Text] [Related]
46. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
47. Nanoparticle formulation of ormeloxifene for pancreatic cancer.
Khan S; Chauhan N; Yallapu MM; Ebeling MC; Balakrishna S; Ellis RT; Thompson PA; Balabathula P; Behrman SW; Zafar N; Singh MM; Halaweish FT; Jaggi M; Chauhan SC
Biomaterials; 2015; 53():731-43. PubMed ID: 25890768
[TBL] [Abstract][Full Text] [Related]
48. Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer.
Sykes PD; Neoptolemos JP; Costello E; Halloran CM
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):343-56. PubMed ID: 22646256
[TBL] [Abstract][Full Text] [Related]
49. A novel multi-stimuli-responsive
Massoumi B; Farnudiyan-Habibi A; Derakhshankhah H; Samadian H; Jahanban-Esfahlan R; Jaymand M
Drug Dev Ind Pharm; 2020 Nov; 46(11):1832-1843. PubMed ID: 32897756
[TBL] [Abstract][Full Text] [Related]
50. Hierarchically Releasing Bio-Responsive Nanoparticles for Complete Tumor Microenvironment Modulation via TGF-β Pathway Inhibition and TAF Reduction.
Zhang J; Zuo T; Yang J; Hu Z; Wang Z; Xu R; Ma S; Wei Y; Shen Q
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2256-2268. PubMed ID: 33423468
[TBL] [Abstract][Full Text] [Related]
51. Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior.
Liu X; Chen Y; Li H; Huang N; Jin Q; Ren K; Ji J
ACS Nano; 2013 Jul; 7(7):6244-57. PubMed ID: 23799860
[TBL] [Abstract][Full Text] [Related]
52. Comparative study between the photodynamic ability of gold and silver nanoparticles in mediating cell death in breast and lung cancer cell lines.
El-Hussein A; Mfouo-Tynga I; Abdel-Harith M; Abrahamse H
J Photochem Photobiol B; 2015 Dec; 153():67-75. PubMed ID: 26398813
[TBL] [Abstract][Full Text] [Related]
53. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
Front Immunol; 2021; 12():643529. PubMed ID: 33679807
[No Abstract] [Full Text] [Related]
54. Interaction of silver and gold nanoparticles in mammalian cancer: as real topical bullet for wound healing- A comparative study.
Sivakumar AS; Krishnaraj C; Sheet S; Rampa DR; Kang DR; Belal SA; Kumar A; Hwang IH; Yun SI; Lee YS; Shim KS
In Vitro Cell Dev Biol Anim; 2017 Aug; 53(7):632-645. PubMed ID: 28462492
[TBL] [Abstract][Full Text] [Related]
55. Advances and potential application of gold nanoparticles in nanomedicine.
Lopes TS; Alves GG; Pereira MR; Granjeiro JM; Leite PEC
J Cell Biochem; 2019 Oct; 120(10):16370-16378. PubMed ID: 31127662
[TBL] [Abstract][Full Text] [Related]
56. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles.
Curley SA; Cherukuri P; Briggs K; Patra CR; Upton M; Dolson E; Mukherjee P
J Exp Ther Oncol; 2008; 7(4):313-26. PubMed ID: 19227011
[TBL] [Abstract][Full Text] [Related]
57. Sequential receptor-mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment.
Shen J; Sun C; Wang Z; Chu Z; Liu C; Xu X; Xia M; Zhao M; Wang C
Int J Pharm; 2021 May; 601():120553. PubMed ID: 33794325
[TBL] [Abstract][Full Text] [Related]
58. The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets.
Farran B; Nagaraju GP
Cytokine Growth Factor Rev; 2019 Aug; 48():11-23. PubMed ID: 31331827
[TBL] [Abstract][Full Text] [Related]
59. KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo.
Liu X; Guo XZ; Li HY; Chen J; Ren LN; Wu CY
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):87-92. PubMed ID: 24463085
[TBL] [Abstract][Full Text] [Related]
60. Vibrating droplet generation to assemble zwitterion-coated gold-graphene oxide stealth nanovesicles for effective pancreatic cancer chemo-phototherapy.
Thapa RK; Ku SK; Choi HG; Yong CS; Byeon JH; Kim JO
Nanoscale; 2018 Jan; 10(4):1742-1749. PubMed ID: 29308494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
